Jingling Su
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis 4
- IL-33, ST2, and ILC Pathways 3
- Immune Cell Function and Interaction 2
- Genetics top 10%
- Inflammatory Bowel Disease 10
- Gastroenterology top 10%
- Gastrointestinal motility and disorders 2
-
- Inflammatory Bowel Disease 10
-
- Clostridium difficile and Clostridium perfringens research 3
-
- Gut microbiota and health 3
-
- Microscopic Colitis 2
- Co-authors
- Zhanju LiuPraveen Kumar YadavJunshan WangFei KePing‐Chang YangTengfei ChenJianlin RenChi Chen
- Cited by
- ImmunologyGeneticsGastroenterology
- Journals
- Scientific Reports (2 papers)Frontiers in Cellular and Infection Microbiology (1 paper)Annals of Translational Medicine (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Jingling Su
16 papers receiving 501 citations
Peers
Comparison fields: 5 of 65
- Immunology 256
- Genetics 179
- Gastroenterology 31
- Genetics 43
- Pathology and Forensic Medicine 63
Countries citing papers authored by Jingling Su
This map shows the geographic impact of Jingling Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingling Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingling Su more than expected).
Fields of papers citing papers by Jingling Su
This network shows the impact of papers produced by Jingling Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingling Su. The network helps show where Jingling Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingling Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 26 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 3 | |
| 10 | 2019 | 26 | |
| 11 | Interleukin-25 enhances the capacity of mesenchymal stem cells to induce intestinal epithelial cell regeneration. | 2017 | 10 |
| 12 | Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype. | 2017 | 32 |
| 13 | 2013 | 86 | |
| 14 | 2011 | 44 | |
| 15 | 2011 | 121 | |
| 16 | 2009 | 123 |
About Jingling Su
Jingling Su is a scholar working on Complementary and Manual Therapy, Gastroenterology, Genetics, Immunology and Infectious Diseases, having authored 16 papers that have together received 509 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (10 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers), IL-33, ST2, and ILC Pathways (3 papers), Gut microbiota and health (3 papers), Immune Cell Function and Interaction (2 papers), Microscopic Colitis (2 papers) and Gastrointestinal motility and disorders (2 papers). The work is most often cited by research in Immunology (256 citations), Genetics (179 citations), Gastroenterology (31 citations), Genetics (43 citations) and Pathology and Forensic Medicine (63 citations). Jingling Su has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Zhanju Liu, Praveen Kumar Yadav, Junshan Wang, Fei Ke, Ping‐Chang Yang, Tengfei Chen, Jianlin Ren, Chi Chen, Maochun Tang and Changqin Liu. Their work appears in journals such as Scientific Reports, Frontiers in Cellular and Infection Microbiology, Annals of Translational Medicine, Medicine and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.